000 00991 a2200277 4500
005 20250513233351.0
264 0 _c20010628
008 200106s 0 0 eng d
022 _a0006-341X
024 7 _a10.1111/j.0006-341x.2001.00309.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeung, D H
245 0 0 _aA Bayesian decision approach for sample size determination in phase II trials.
_h[electronic resource]
260 _bBiometrics
_cMar 2001
300 _a309-12 p.
_bdigital
500 _aPublication Type: Comment; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aBayes Theorem
650 0 4 _aBiometry
650 0 4 _aClinical Trials, Phase II as Topic
_xstatistics & numerical data
650 0 4 _aDecision Theory
650 0 4 _aHumans
650 0 4 _aSample Size
700 1 _aWang, Y G
773 0 _tBiometrics
_gvol. 57
_gno. 1
_gp. 309-12
856 4 0 _uhttps://doi.org/10.1111/j.0006-341x.2001.00309.x
_zAvailable from publisher's website
999 _c11189339
_d11189339